Powering up medical affairs

In a world where health systems are increasingly focused on value-based pricing and personalized treatments, the heightened emphasis on scientific exchange between the pharmaceutical, biotech, medical device and diagnostic industry and its customers has never been greater. The perception that […]

Read More

In the track-and-trace trenches

By all counts, the global pharma traceability initiative—driven by the Drug Supply Chain Security Act (DSCSA) in the US, and the Falsified Medicines Directive in Europe—is moving ahead, with equipment and software contracts being placed, and project managers getting to […]

Read More
| 1 Comment

Changing of the guard at PDMA Alliance

Lisa A. Butler, newly elected president of the PDMA Alliance, has been an Alliance Board Member for the past three years. She is an associate director of DEA/PDMA Compliance for Novartis Business Services. For the last 25 years, she has […]

Read More

When it Comes to Compliance, Learning Never Stops

Having the privilege to serve 
on the Alliance’s board affords me an enormous and gratifying experience, highlighted by the opportunity to participate in developing a new conference program each year. From the end of one year’s conference to the next, […]

Read More

A conversation with Terry Hisey, Deloitte

  As one of the Big Four accounting and advisory firms, Deloitte deals with a large portion of the pharmaceutical industry, both domestically and internationally. In fact, the company says that it has not only the leading position with pharma, […]

Read More